Sun Pharma posts Q1 profit of ₹1,444.17 cr.

Sun Pharma posts Q1 profit of ₹1,444.17 cr.

The Hindu

Sun Pharmaceutical Industries Ltd. reported a consolidated net profit of ₹1,444.17 crore for the first quarter ended June 30. The company had reported a net loss of ₹1,655.60 crore in the year-earli

Sun Pharmaceutical Industries Ltd. reported a consolidated net profit of ₹1,444.17 crore for the first quarter ended June 30. The company had reported a net loss of ₹1,655.60 crore in the year-earlier period. Consolidated sales from operations at ₹9,669.4 crore grew 29% over Q1 last year. India sales at ₹3,308.4 crore grew 39% compared with Q1 last year, while U.S. finished dosage sales grew 35% to $380 million. Emerging markets sales grew 25% to $218 million, while rest of the world sales grew 35% to $ 185 million.
Read full story on The Hindu
Share this story on:-
More Related News
MTNL stock zooms more than 18% on robust earnings from asset monetisation

MTNL shares surge 18% after earning ₹2,134.61 crore from land monetisation, government informs Parliament. Market benchmarks rise.

Passenger vehicles wholesales rise 2% in Feb 2025, two-wheeler sales drop 9% YoY: SIAM

February 2025 saw a 2% increase in passenger vehicle sales in India, with upcoming festivals expected to boost demand.

Fitch revises Outlook on four Adani Group entities to Stable from Negative

Fitch Ratings revises outlook on Adani Group entities to Stable, affirms 'BBB-' rating, and takes rating action on other bonds.

Sensex, Nifty climb in early trade on robust domestic macro data, global cues

Equity market benchmarks Sensex and Nifty rise on strong domestic data and global trends, led by ICICI Bank and Reliance: Follow The Hindu’s updates on the Sensex and Nifty

Monopoly Go game maker Scopely to buy Pokemon Go team

Scopely will pay $3.5 billion to acquire Niantic’s game unit, including the studio behind Pokemon Go.

Rupee jumps 19 paise to 87.03 against US dollar in early trade

Follow The Hindu’s updates on the rupee : Mumbai forex analysts report on rupee's gains against the dollar amid global tariff tensions and economic data.

Trump's FTC advances broad antitrust probe of Microsoft: Report

The U.S. Federal Trade Commission is moving ahead with an antitrust probe of Microsoft, Bloomberg News reported.

Intel hires former board member Lip-Bu Tan as new CEO in struggling chipmaker’s latest comeback attempt

Intel hires semiconductor industry veteran Lip-Bu Tan as CEO to revive struggling company amid leadership changes and financial challenges.

India to be the most preferred IPO market globally by 2035: Nilekani

Nandan Nilekani predicts India as top IPO market by 2035 with 1 million startups and $8 trillion economy potential.

BNW Developments ties up with IHCL to bring Taj Wellington Mews branded residences to UAE

BNW Developments partners with Taj to bring luxury living to UAE's Al Marjan Island, Ras Al Khaimah.

Sensex, Nifty end moderately lower on selling in IT, telecom stocks

Equity indices Sensex and Nifty close lower amid global economic concerns, with IT and telecom stocks leading the decline.

Rupee inches up 2 paise to close at 87.19 against U.S. dollar

Rupee closes at 87.19 against US dollar amid tariff uncertainties, crude oil prices, and global market volatility.

NCLAT rejects IRDAI pleas against Shriram Group’s insurance arms merger proposals

NCLAT rejects IRDA pleas against Shriram Group insurance arm mergers, citing no statutory bar under Insurance Act.